A useful way to think about how clinicians actually consume medical information is to separate it into two genuinely different modes. Some information should be pushed to a doctor before they know they need it, surfacing developments they would not otherwise have thought to look for. Other information should be available to pull, retrieved precisely when a specific clinical question arises during a consultation or in preparation for one. Few single products do both of these well, and expecting one tool to do so may be asking more of it than the underlying problem allows.
The Monday Clinical Brief's push model
The Monday Clinical Brief operates as weekly, specialty-specific literature surveillance: every newly published article from the top five journals in a clinician's chosen specialty is automatically identified and summarised, arriving as a single concise Monday email. This allows a clinician to scan recent developments in their field without needing to conduct repeated manual PubMed searches on their own initiative, which in practice tends to happen rarely and inconsistently given competing clinical demands.
iatroX's pull model
iatroX works the other way round. A clinician begins with a specific clinical question, and the platform retrieves and synthesises relevant UK clinical guidance alongside supporting evidence, oriented specifically towards the practical decisions a UK clinician actually needs to make: prescribing, investigation, and referral within the NHS system.
Why neither workflow fully replaces the other
A question-answering platform cannot reliably alert a clinician to a study they do not yet know exists, since by definition it only responds to questions already asked. A weekly journal digest, equally, cannot provide a complete, patient-specific answer during an actual consultation, since it is built for scheduled review rather than real-time retrieval. Reading about the latest published study does not automatically establish what NICE currently recommends, since guidance and primary literature move on different timelines. And current guidance may simply not yet include a recently published, potentially practice-changing trial, since guideline committees review evidence periodically rather than continuously.
A practical combined workflow worth adopting
A reasonable structure for using both tools together might run as follows. Receive the Monday Clinical Brief at the start of the week. Scan the two or three highlighted studies in the weekly overview. Save anything that looks genuinely relevant to current practice or worth logging for CPD. Read the original publication in full before allowing any single new study to change actual practice. Use iatroX to establish the current UK guideline position on the same topic. Identify specifically whether the newer evidence supports, challenges, or simply post-dates the existing recommendation. And record the resulting learning, in the clinician's own words, for appraisal or professional development purposes.
A worked illustration
Consider a Monday digest that identifies a new cardiovascular trial. The clinician reads the summary, then examines the original paper's population, endpoints and limitations directly, rather than stopping at the digest's summary alone. They then use iatroX to check the current NICE pathway for the relevant condition, along with prescribing requirements and monitoring recommendations. Having done both, they are now in a position to distinguish genuinely emerging evidence from established NHS practice, and to judge whether the new trial is something to watch, something to discuss with colleagues, or something that already has practical implications worth acting on.
What the two products genuinely share
Both were founded by practising UK clinicians who built the tool to solve a problem they experienced directly in their own work. Both address a specific, identifiable gap in NHS practice rather than a generic ambition to "improve healthcare with AI." Both maintain visible, direct links to underlying source material rather than asking the clinician to trust a synthesis on faith. And neither needs to present itself as a replacement for primary research or professional clinical judgement, because neither is trying to be.
The Monday Clinical Brief's own framing
The Monday Clinical Brief itself has described the two services as complementary in exactly this way: the digest supporting systematic weekly coverage of what is newly published, while iatroX provides UK-focused, point-of-care answers to the specific questions that arise once a clinician is actually working through a case.
Why a push-plus-pull system may outperform a single all-purpose tool
Expecting one AI product to perform literature surveillance, evidence appraisal, guideline retrieval and point-of-care decision support equally well is a genuinely tall order, and most products that attempt all of it end up doing each part less thoroughly than a tool built specifically for that one task. A deliberately combined push-plus-pull system, using each tool for the job it is actually built for, is a more realistic and more effective way to stay current in practice.